Home LiteratureArticle Details
PMID: 11221883 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Cancer research ·Vol. 61 ·No. 3 ·2001-02-01 ·Pages 921-5

Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S

Abstract

We analyzed Wilms' tumor suppressor 1 (WT1) expression and its regulation by promoter methylation in a panel of normal breast epithelial samples and primary carcinomas. Contrary to previous reports, WT1 protein was strongly expressed in primary carcinomas (27 of 31 tumors) but not in normal breast epithelium (1 of 20 samples). Additionally, the WT1 promoter was methylated in 6 of 19 (32%) primary tumors, which nevertheless expressed WT1. The promoter is not methylated in normal epithelium. Thus, although tumor-specific methylation of WT1 is established in primary breast cancer at a low frequency, other transcriptional regulatory mechanisms appear to supercede its effects in these tumors. Our results demonstrate expression of WT1 in mammary neoplasia, and that WT1 may not have a tumor suppressor role in breast cancer.

MeSH Terms
Breast/metabolism Breast Neoplasms/genetics,metabolism Cell Line Cell Line, Transformed CpG Islands DNA Methylation DNA-Binding Proteins/biosynthesis,genetics Epithelium/metabolism Female Gene Expression Genes, Wilms Tumor/genetics Humans Promoter Regions, Genetic RNA, Messenger/biosynthesis,genetics Reverse Transcriptase Polymerase Chain Reaction Transcription Factors/biosynthesis,genetics Tumor Cells, Cultured WT1 Proteins
Chemicals
DNA-Binding Proteins RNA, Messenger Transcription Factors WT1 Proteins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Loeb D M
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.
Evron E
Patel C B
Sharma P M
Niranjan B
Buluwela L
Weitzman S A
Korz D
Sukumar S
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2001-02-01
Pages
921-5
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · P50-CA88843 · United States
NCI NIH HHS · R01-CA48493 · United States
NCI NIH HHS · T32 CA60441-06 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com